Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination Jeffery D Haines et al. Nature Neuroscience – April, 2015. The following content is accessible for members only, please sign in.
Read more